Skip to main content
Have a personal or library account? Click to login
Epigenetic regulation of fetal bone development and placental transfer of nutrients: progress for osteoporosis Cover

Epigenetic regulation of fetal bone development and placental transfer of nutrients: progress for osteoporosis

Open Access
|Feb 2012

References

  1. Antoniades L, MacGregor AJ, Andrew T, Spector TD. (2003). Association of birth weight with osteoporosis and osteoarthritis in adult twins.: 791-796.
  2. Baek WY and Kim JE. (2011). Transcriptional regulation of bone formation.: 126-135.
  3. Bass S, Pearce G, Bradney M, Hendrich E, Delmas PD, Harding A, et al. (1998). Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts.: 500-507.
  4. Bateson P. (2001). Fetal experience and good adult design.: 928-934.
  5. Biniszkiewicz D, Gribnau J, Ramsahoye B et al. (2002). Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality.: 2124-2213.
  6. Bird A. (2001). DNA methylation patterns and epigenetic memory.: 6-21.
  7. Burton GJ, Hempstock J, Jauniaux E. (2001). Nutrition of the human fetus during the first trimester - a review.() S70-S77
  8. Cooney CA, Dave AA, Wolff GL. (2002). Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring.: 2393-2400.
  9. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M. (2006). Developmental origins of osteoporotic fracture.: 337-347.
  10. Cooper GS and Umbach DM. (1996). Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis.: 1841-1849.
  11. Coopere C, Eriksson JG, Forsen T, Osmond C, Tuomilehto J, Barker DJP. (2001). Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study.: 623-629.
  12. Dennison EM, Syddall HE, Fall CH, Javaid MK, Arden NK, Phillips DIW, Cooper C. (2004). Plasma Leptin Concentration and Change in Bone Density among Elderly Men and Women: The Hertfordshire Cohort Study.: 401-406.
  13. Dennison E, Hindmarsh P, Fall C, Kellingray S, Barker D, Phillips D, Cooper C. (1999). Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men.: 3058-3063.
  14. Ensrud KE, Taylor BC, Paudel ML Osteoporotic Fractures in Men Study Group. (2009). Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men.: 2773-2780.
  15. Ferrari SL, Karasik D, Liu J, Karamohamed S, Herbert AG, Cupples LA, Kiel DP. (2004). Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study.: 552-559.
  16. Ferreira JC, Choufani S, Grafodatskaya D, Butcher DT, Zhao C, et al. (2011). WNT2 promoter methylation in human placenta is associated with low birth weight percentile in the neonate.: 440-449.
  17. Gluckman PD, Hanson MA, Cooper C et al. (2008). Effect of in utero and early-life conditions on adult health and disease.: 61-73.
  18. Gupta A, Välimäki VV, Välimäki M, Löyttyniemi E, et al. (2008). Variable number of tandem repeats polymorphism in parathyroid hormone-related protein as predictor of peak bone mass in young healthy Finnish males.: 755-764.
  19. Harvey N, Dennison E, Cooper C. (2008). Epidemiology of osteoporotic fracture, in:(Favus MJ ed) pp 198-203, ASMBR, Washington, 7th ed.
  20. Hunter DJ. (2005). Gene-environment interactions in human diseases.: 287-298.
  21. Javaid MK, Crozier SR, Harvey NC. (2006). Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study.: 36-43.
  22. Javaid MK, Godfrey KM, Taylor P, Robinson SM, Crozier SR et al. (2005). Umbilical cord leptin predicts neonatal bone mass.: 341-347.
  23. Javaid MK, Godfrey KM, Taylor P, Shore SR, Breier B, Arden NK, Cooper C. (2004). Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition.: 56-63.
  24. Jiang YH, Bressler J, Beaudet AL. (2004). Epigenetics and human disease.: 479-510.
  25. Kimball S, El-Hajj Fuleihan G, Vieth R. (2008). Vitamin D: a growing perspective.: 339-414.
  26. Koller DL, Liu G, Econs MJ, Morin P, Christian JC, et al. (2001). Genome screen for quantities trail loci underlying normal variation in femoral structure.(Suppl.1): 1094.
  27. Koller DL, Econs M J, Rodriguez LA, Christian JC, et al. (2000). Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis.: 3116-3120.
  28. Lillycrop KA, Slater-Jefferies JL, Hanson MA et al. (2007). Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications.: 1064-1073.
  29. Long JR, Xiong DH, Recker RR, Deng HW. (2005). The genetics of osteoporosis.: 205-218.
  30. Martin R, Harvey NC, Crozier SR, et al. (2007). Placental calcium transporter (PMCA3) gene expression predicts intrauterine bone mineral accrual.: 1203-1208.
  31. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F et al. (2008). BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation.: 29119-29125
  32. Morgan HD, Santos F, Green K, Dean W, Reik W. (2005). Epigenetic reprogramming in mammals.: 47-58.
  33. Namgung R, Tsang RC. (2003). Bone in the pregnant mother and newborn at birth.: 1-11.
  34. Nelissen EC, van Montfoort AP, Dumoulin JC, Evers JL. (2011). Epigenetics and the placenta.: 397-417.
  35. Nissenson RA, Jüppner H. (2009). Parathyroid hormone, in:, pp 123-127, John Wiley & Sons, Hoboken, (NJ).
  36. Ralston SH. (2010). Genetics of osteoporosis. Ann NY Acad Sci: 181-189.
  37. Reneland RH, Mah S, Kammerer S, Hoyal CR, Marnellos G, Wilson SG, Sambrook PN et al. (2005). Association between a variation in the phosphodiesterase 4D gene and bone mineral density.: 9.
  38. Scillitani A, Jang C, Wong BY, Hendy GN, Cole DE, et al. (2006). A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women.: 416-421.
  39. Sundar IK and Rahman I. (2011). Vitamin D and susceptibility of chronic lung diseases: role of epigenetics.: 1-10.
  40. Tabano S, Colapietro P, Cetin I, Grati FR, Zanutto S, et al. (2011). Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction.: 313-24.
  41. Tang W, Ho S. (2007). Epigenetic reprogramming and imprinting in origins of disease.: 173-182.
  42. Vilariño-Güell C, Miles LJ, Duncan EL, Ralston SH. (2007). PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton.: 270-278.
  43. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. (2004). Epigenetic programming by maternal behavior.: 847-854.
  44. Williams FM, Spector TD. (2006). Recent advances in the genetics of osteoporosis.: 27-35.
  45. Winsloe C, Earl S, Dennison EM, Cooper C, Harvey NC. (2009). Early life factors in the pathogenesis of osteoporosis.: 140-144.
  46. Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, Sha BY, Tang ZH. (2009). Genome-wide association and follow-up replication studies identifiedandas bone mass candidate genes in different ethnic groups.: 388-398.
DOI: https://doi.org/10.2478/v10102-011-0026-6 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 167 - 172
Published on: Feb 6, 2012
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2012 Georgeta Bocheva, Nadka Boyadjieva, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.